BioDelivery Sciences International, Inc. (BDSI) plummeted -3.03 percent and ended the day at $1.6. The Average Volume of the company is 424.9 Million.
Cantor Fitzgerald Downgrade its coverage for BioDelivery Sciences International, Inc. (BDSI) in a note sent to investors on 11-May-16. The research firm Downgrade the stock to Hold. Moreover, Piper Jaffray issued Initiated rating for the stock on 8-Feb-16. Cantor Fitzgerald also Initiated the company to Buy on 4-Nov-15, 2016. Additionally, FBR Capital Initiated its ratings on the stock to Outperform.
The highest price BDSI stock touched in the last 12 month was $3.88 and the lowest price it hit in the same period was $1.50. The stock has a Return on Assets of -93.9 percent, Return on Investment of 0 percent and a Return on Equity of 0 percent. The company’s market cap is $87.67 Million.
BioDelivery Sciences International, Inc. (BDSI) has been given an average price target of $3.79 from analysts, according to data collected by Finviz.
Now we look at the Moving Averages, the 200-day is -25.57, the 50-day is -16.28 and the 20-day is -11.48. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.
Looking forward, the company is expected to report earnings of $-0.22 per share for the current quarter. Revenue is expected in between 30.28 Million and 25.73 Million with an average of 27.54 Million.
BioDelivery Sciences International, Inc. (BDSI) has a mean recommendation of 1.29, according to data compiled by Zacks Investment Research. The recommendation scale measures the value from 1 to 5, where 1 means ‘’Strong Buy’’ and 5 stands for ’’Sell’’.
BioDelivery Sciences International, Inc. (BDSI) performance during the last one year Degraded -55.8 percent, while its year to date (YTD) performance showed a Negative trend of -8.57 percent. The stock Fell -31.91 percent over the past six months. The stock’s quarterly performance indicates a Negative momentum of -13.51 percent, whereas its last one month trend is Pessimistic with -15.79 percent. Its weekly performance showed a downward trend of -5.88 percent.
Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 0 percent, operating profit margin was 0 percent, whereas gross profit margin stands at 27.6 percent. Beta factor was calculated at 1.23.
BioDelivery Sciences International, Inc. (BDSI) has 54.82 Million shares outstanding and 51.97 Million shares were floated in market. The short ratio in the company’s stock is documented at 10.49 and the short float is around of 8.58%. The stock’s average true range of stands at 0.12, while the relative strength index is 29.61.
Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 2, current ratio was 2.2.